TSUYOSHI KOBAYASHI

Last Updated :2024/04/03

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Associate Professor
Web Site
E-mail
tsukobahiroshima-u.ac.jp
Self-introduction
I am aiming to improve the surgical treatment results for hepatobiliary cancer

Basic Information

Major Professional Backgrounds

  • 2020/06/01, Graduate School of Biomedical and Health Sciences, Gastroenterological and Transplant Surgery, Associate professor
  • 2015/10/01, Hiroshima university, Institute of Biomedical & Health Sciences, Lecturer
  • 2009/04/01, 2015/09/30, Hiroshima University, Hospital, Assistant Professor
  • 2008/04/01, 2009/03/31, Hiroshima University Hospital, Clinical Fellow

Educational Backgrounds

  • Hiroshima University, Japan, 2006/03
  • Hiroshima University, Japan, 1996/03

Academic Degrees

  • Hiroshima University

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Digestive surgery

Research Keywords

  • cancer metastasis
  • gastroenterological cancer
  • Hepato-Biliary-Pancreatic Surgery

Affiliated Academic Societies

  • Japan Biliary Association, 2020/04
  • Japan Surgical Society, 1996
  • The Japanese Society of Gastroenterological Surgery, 1996
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2007/11
  • The Japan Society of Hepatology, 2007/12
  • The Japan Society for Transplantation, 2008
  • the Japan Society for Endoscopic Surgery, 2008
  • The Japanese Cancer Association, 2010

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  4. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  5. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  6. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Gastroenterological and Transplant Surgery
  7. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Gastroenterological and Transplant Surgery

Research Activities

Academic Papers

  1. Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients, Am Surg, 31348211041562-31348211041562, 20210830
  2. Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection, JOURNAL OF GASTROENTEROLOGY, 57(9), 676-683, 202209
  3. Downregulation of thrombomodulin contributes to ischemia-reperfusion injury in mice with steatotic liver, HEPATOLOGY RESEARCH, 52(9), 762-772, 202209
  4. Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology, SURGERY, 171(5), 1303-1310, 202205
  5. Metachronous colorectal liver metastasis that occurred 10 years after laparoscopic colectomy: a case report, SURGICAL CASE REPORTS, 8(1), 20220801
  6. Hepatic resection using intraoperative ultrasound and near-infrared imaging with indocyanine green fluorescence detects hepatic metastases from gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 91, 202202
  7. Clostridium butyricum affects nutrition and immunology by modulating gut microbiota, BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 41(2), 30-36, 2022
  8. Successful Resection of Solitary Abdominal Wall Metastasis of Sarcomatous Intrahepatic Cholangiocarcinoma, CASE REPORTS IN GASTROENTEROLOGY, 13(1), 66-72, 2019
  9. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 29(3), 385-393, 202203
  10. ★, A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB (Oxford), 23(1), 134-143, 2021
  11. Validation of the Tokyo guideline 2018 treatment proposal for acute cholecystitis from a single-center retrospective analysis, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(1), 14-20, 202101
  12. ★, A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB, 23(1), 134-143, 202101
  13. Induced hepatic stellate cell integrin, alpha 8 beta 1, enhances cellular contractility and TGF beta activity in liver fibrosis, JOURNAL OF PATHOLOGY, 253(4), 366-373, 202104
  14. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer, EJSO, 47(3), 613-619, 202103
  15. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 19(1), 20210405
  16. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients, BMC NEPHROLOGY, 22(1), 20210615
  17. ★, Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification, BMC CANCER, 21(1), 20210605
  18. Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy, MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 21, 171-179, 20210611
  19. Long-term survival by repeat resection for metastases from primary retroperitoneal leiomyosarcoma: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 82, 202105
  20. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib, INTERNAL MEDICINE, 60(13), 2047-2053, 2021
  21. Usefulness and safety of midline incision for right-sided hepatectomy: Cohort study, ANNALS OF MEDICINE AND SURGERY, 67, 202107
  22. Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review, CLINICAL CASE REPORTS, 8(1), 108-115, 202001
  23. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection, EUROPEAN JOURNAL OF RADIOLOGY, 124, 202003
  24. Simulation and navigation of living donor hepatectomy using a unique three-dimensional printed liver model with soft and transparent parenchyma, SURGERY TODAY, 50(3), 307-313, 202003
  25. Grade IV traumatic pancreatic injury with primary duodenum malignant lymphoma following pancreatoduodenectomy: a case report, SURGICAL CASE REPORTS, 6(1), 20200318
  26. Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report, CLINICAL JOURNAL OF GASTROENTEROLOGY, 13(3), 421-427, 202006
  27. Essential updates 2018/2019: Liver transplantation, ANNALS OF GASTROENTEROLOGICAL SURGERY, 4(3), 195-207, 202005
  28. Hemorrhoidectomy for elderly patients aged 75 years or more, before and after studies, ANNALS OF MEDICINE AND SURGERY, 55, 88-92, 202007
  29. Impact of systematic segmentectomy for small hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 27(6), 331-341, 202006
  30. ★, Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution, J Gastroenterol, 55(9), 877-887, 2020
  31. ★, Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma, J Hepatobiliary Pancreat Sci, 2020
  32. ★, PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study, Int J Surg, 80, 84-90, 2020
  33. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study, INTERNATIONAL JOURNAL OF SURGERY, 80, 84-90, 202008
  34. Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy, BMC GASTROENTEROLOGY, 20(1), 20200808
  35. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution, JOURNAL OF GASTROENTEROLOGY, 55(9), 877-887, 202009
  36. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response, ONCOIMMUNOLOGY, 9(1), 2020
  37. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO), SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 34(11), 5055-5061, 202011
  38. Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery, SURGICAL CASE REPORTS, 6(1), 20201007
  39. Antithrombin attenuates the progression of hepatocellular carcinoma by regulating neutrophil/interleukin-8 signaling, HEPATOLOGY RESEARCH, 50(11), 1284-1296, 202011
  40. Identification of risk factors for open conversion from laparoscopic cholecystectomy for acute cholecystitis based on computed tomography findings, SURGERY TODAY, 50(12), 1657-1663, 202012
  41. Obliteration of a Portosystemic Shunt by Hybrid Interventional Radiology Using a Transmesenteric Approach Under Minilaparotomy After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(9), 2762-2766, 202011
  42. Impact on biliary complications of donor abdominal aortic calcification among living donor liver transplantation: a retrospective study, TRANSPLANT INTERNATIONAL, 33(12), 1745-1753, 202012
  43. De novo hepatocellular carcinoma in living donor liver grafts: A Japanese multicenter experience, HEPATOLOGY RESEARCH, 50(12), 1365-1374, 202012
  44. Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 27(12), 931-941, 202012
  45. Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection, BMC GASTROENTEROLOGY, 20(1), 20201007
  46. Impact of Abdominal Aortic Calcification Among Liver Transplantation Recipients, LIVER TRANSPLANTATION, 25(1), 79-87, 201901
  47. Antithrombin Insufficiency Promotes Susceptibility to Liver Tumorigenesis, JOURNAL OF SURGICAL RESEARCH, 236, 198-208, 201904
  48. ★, Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation, PLOS ONE, 14(3), 20190307
  49. Laparoscopic cholecystectomy for acute cholecystitis in a patient with left-sided gallbladder: a case report, SURGICAL CASE REPORTS, 5, 20190405
  50. ★, Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study, PLOS ONE, 14(5), 20190529
  51. Risk Factors for Refractory Ascites After Living Donor Liver Transplant, TRANSPLANTATION PROCEEDINGS, 51(5), 1516-1519, 201906
  52. Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience, JOURNAL OF GASTROENTEROLOGY, 54(7), 660-666, 201907
  53. Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects, HEPATOLOGY RESEARCH, 49(6), 663-675, 201906
  54. ★, Experience and outcomes in living donor liver procurement using the water jet scalpel, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 26(8), 370-376, 201908
  55. Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 51(6), 1934-1938, 2019
  56. Characteristics recurrence pattern of cholangiolocellular carcinoma as intrahepatic bile duct tumor growth following curative resection: a case report, SURGICAL CASE REPORTS, 5(1), 20190905
  57. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy, TRANSPLANTATION PROCEEDINGS, 51(8), 2740-2744, 201910
  58. ★, Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade, HEPATOLOGY RESEARCH, 49(10), 1218-1226, 201910
  59. Utility of Doppler Ultrasonography in Liver Transplantation With Celiac Axis Compression Syndrome: A Case Report, TRANSPLANTATION PROCEEDINGS, 51(9), 3103-3106, 201911
  60. Amputation neuroma derived from a remnant cystic duct 30 years after cholecystectomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 64, 184-187, 2019
  61. ★, Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma, ANNALS OF GASTROENTEROLOGICAL SURGERY, 3(6), 667-675, 201911
  62. Visceral Adipose Tissue and Skeletal Muscle Index Distribution Predicts Severe Pancreatic Fistula Development After Pancreaticoduodenectomy, ANTICANCER RESEARCH, 38(2), 1061-1066, 201802
  63. Utility of hepatobiliary scintigraphy for recurrent reflux cholangitis following choledochojejunostomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 42, 104-108, 2018
  64. A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 44, 131-134, 2018
  65. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis, ANNALS OF SURGICAL ONCOLOGY, 25(6), 1699-1708, 201806
  66. ★, Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 54, 156-162, 201806
  67. Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report, SURGICAL CASE REPORTS, 4, 2018
  68. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, 201808
  69. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 25(8), 370-376, 201808
  70. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study, INTERNATIONAL JOURNAL OF SURGERY, 57, 1-7, 201809
  71. Characteristics of the portal vein thrombosis recurrence pattern without liver parenchymal invasion from colorectal cancer: a case report, SURGICAL CASE REPORTS, 4, 2018
  72. Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis, ANNALS OF GASTROENTEROLOGICAL SURGERY, 2(5), 383-393, 201809
  73. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma, EJSO, 44(10), 1573-1579, 201810
  74. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates, TRANSPLANTATION PROCEEDINGS, 49(1), 98-101, 2017
  75. ★, Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 201701
  76. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 31, 5-9, 2017
  77. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 39, 206-213, 201703
  78. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 201705
  79. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report, SURGICAL CASE REPORTS, 3, 20170525
  80. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 201707
  81. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 201707
  82. ★, Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study., Int J Surg., 44(44), 223-228, 2017
  83. ★, Application of endobronchial ultrasonography in laparoscopic liver segmentectomy in an animal model., Asian J Endosc Surg., 10(2), 209-212, 201705
  84. ★, Viability of Airborne Tumor Cells during Excision by Ultrasonic Device., Surg Res Pract., 2017
  85. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma (vol 41, pg 1860, 2017), WORLD JOURNAL OF SURGERY, 41(7), 1857-1859, 2017
  86. ★, Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 2017
  87. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma, ANTICANCER RESEARCH, 37(10), 5863-5870, 2017
  88. Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas, LANGENBECKS ARCHIVES OF SURGERY, 402(5), 745-755, 2017
  89. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 2017
  90. Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy, SURGERY TODAY, 47(10), 1230-1237, 2017
  91. ★, Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response, HEPATOLOGY RESEARCH, 47(11), 1186-1195, 2017
  92. Propensity score-matching analysis of the efficacy of late cholecystectomy for acute cholecystitis, AMERICAN JOURNAL OF SURGERY, 214(2), 262-266, 2017
  93. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation, TRANSPLANT INFECTIOUS DISEASE, 19(5), 2017
  94. Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(11), 616-626, 2017
  95. Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 39, 29-33, 2017
  96. 3D printing model of the intrahepatic vessels for navigation during anatomical resection of hepatocellular carcinoma, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 41, 219-222, 2017
  97. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 2017
  98. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 2017
  99. Patients with early recurrence of hepatocellular carcinoma have poor prognosis, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16(3), 279-288, 2017
  100. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 2017
  101. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 2017
  102. Periostin Promotes Malignant Potential by Induction of Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma, HEPATOLOGY COMMUNICATIONS, 1(10), 1099-1109, 201712
  103. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  104. An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 43-50, 2016
  105. The Incidence of Posthepatectomy Liver Failure Defined by the International Study Group of Liver Surgery among Living Donors, JOURNAL OF GASTROINTESTINAL SURGERY, 20(4), 757-764, 201604
  106. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  107. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  108. ★, h-prune affects anaplastic thyroid cancer invasion and metastasis, ONCOLOGY REPORTS, 35(6), 3445-3452, 201606
  109. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, 201606
  110. Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report, SURGICAL CASE REPORTS, 2, 20160317
  111. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, 201606
  112. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, 20160909
  113. Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder Carcinoma Outcomes Following Surgery with Curative Intent, ANTICANCER RESEARCH, 36(9), 4887-4894, 201609
  114. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter, Surg Case Rep, 2(1), 89, 201612
  115. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 201612
  116. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, 20161207
  117. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  118. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, 2016
  119. ★, h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases, INTERNATIONAL JOURNAL OF CANCER, 139(4), 812-823, 2016
  120. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, 2016
  121. Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder Carcinoma Outcomes Following Surgery with Curative Intent, ANTICANCER RESEARCH, 36(9), 4887-4894, 2016
  122. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 2016
  123. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells, INTERNATIONAL JOURNAL OF CANCER, 136(4), E3-E13, 20150215
  124. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, 201501
  125. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, LANGENBECKS ARCHIVES OF SURGERY, 400(4), 471-476, 201505
  126. Administration of Antithrombin III Attenuates Posthepatectomy Liver Failure in Hepatocellular Carcinoma, DIGESTIVE SURGERY, 32(3), 173-180, 2015
  127. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, 201509
  128. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy, EJSO, 41(11), 1515-1521, 201511
  129. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 201510
  130. A case of biliary cystic tumor with repeated hemobilia, SURGICAL CASE REPORTS, 1, 2015
  131. Obstructive jaundice caused by a giant liver hemangioma with Kasabach-Merritt syndrome: a case report, SURGICAL CASE REPORTS, 1, 2015
  132. Pseudolymphoma of the liver: a case report and literature review, SURGICAL CASE REPORTS, 1, 2015
  133. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, 2015
  134. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, 2015
  135. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 2015
  136. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, 201404
  137. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, 201404
  138. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 201412
  139. The Impact of Fc gamma Receptor Polymorphism on Infection-Related Complications in ABO-Incompatible Living Donor Liver Transplantation Under Rituximab-Based Immunosuppressive Regimen., LIVER TRANSPLANTATION, 20, S149-S149, 2014
  140. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 2014
  141. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, 201303
  142. ★, Prevention of recurrence after curative treatment for hepatocellular carcinoma, SURGERY TODAY, 43(12), 1347-1354, 201312
  143. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, 201304
  144. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, 20130806
  145. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, 20130627
  146. The impact of Fc gamma receptor polymorphisms on the outcome of ABO-incompatible living donor liver transplantation, XENOTRANSPLANTATION, 20(5), 322-322, 2013
  147. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, 2013
  148. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, 2013
  149. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, 2013
  150. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, 2013
  151. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, 201202
  152. A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case, SURGERY TODAY, 42(5), 505-508, 201205
  153. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, 201201
  154. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, 201203
  155. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, 201203
  156. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, 20120527
  157. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, 201209
  158. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, 2012
  159. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, 2012
  160. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, 2012
  161. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, 2012
  162. Effects of canopy N uptake on foliar CO2 assimilation rates and biomass production and allocation in Japanese red pine seedlings, CANADIAN JOURNAL OF FOREST RESEARCH-REVUE CANADIENNE DE RECHERCHE FORESTIERE, 42(7), 1395-1403, 2012
  163. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, 2012
  164. ★, Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18(5), 689-699, 201109
  165. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  166. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B, WORLD JOURNAL OF SURGERY, 35(4), 834-841, 201104
  167. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, 20110701
  168. Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria, JOURNAL OF GASTROINTESTINAL SURGERY, 15(7), 1173-1181, 201107
  169. Involvement of myeloid derived suppressor cells (MDSC) in the changes of plasma amino acid profiles in cancer disease, CANCER RESEARCH, 71, 2011
  170. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  171. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, 2011
  172. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, 2009
  173. Hepatectomy for Hepatocellular Carcinoma in Elderly Patients Aged 75 Years or More, JOURNAL OF GASTROINTESTINAL SURGERY, 13(4), 695-701, 2009
  174. Feasibility and Safety for Using Recipient's Middle Hepatic Vein for Drainage of the Right Paramedian Sector in Right Liver Graft, TRANSPLANTATION, 88(1), 144-145, 2009
  175. BACTERIAL AND FUNGAL INFECTIONS IN LIVING DONOR LIVER TRANSPLANTATION, TRANSPLANT INTERNATIONAL, 22, 202-202, 2009
  176. Role of double-balloon endoscopy in the diagnosis of small-bowel tumors: the first Japanese multicenter study, GASTROINTESTINAL ENDOSCOPY, 70(3), 498-504, 2009
  177. Suppression of Hepatocellular Carcinoma Recurrence After Rat Liver Transplantation by FTY720, a Sphingosine-1-Phosphate Analog, TRANSPLANTATION, 88(8), 980-986, 2009
  178. ★, Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions, Molecular and cellular biology, 26(3), 898-911, 20060101
  179. ★, A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial), SURGERY, 170(4), 1140-1150, 202110
  180. Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab, MEDICINE, 100(42), 20211022
  181. Treatment of multiple huge liver cysts in a hybrid operating room: a case report, SURGICAL CASE REPORTS, 7(1), 20211029
  182. Gradually progressive cholangiolocellular carcinoma: a case report, SURGICAL CASE REPORTS, 7(1), 20211220
  183. Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study, ANNALS OF GASTROENTEROLOGICAL SURGERY, 6(1), 149-158, 202201

Invited Lecture, Oral Presentation, Poster Presentation

  1. Effect of Abdominal Aortic Calcification on Renal Function After Liver Transplantation, Ryuta Ide, Masahiro Ohira, Ryosuke Arata, Koki Imaoka, Keishi Hakoda, Kosuke Ono,Tetsuya Mochizuki, Naofumi Tsukiyama, Akhmet Seidakhmetov, Hiroaki Yamane, Koki Sato,Yuki Imaoka, Hiroaki Mashima, Doskali Marlen, Ryosuke Nakano, Masakazu Hashimoto, Naoki Tanimine, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Hideki Ohdan, American Transplant Congress 2022, 2022/06/04, Without Invitation, English, Boston
  2. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO), Yamamoto M, Kobayashi T, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka T, Ohdan H, The 31st World Congress of the International Association of Surgeons, Gastroenterologist and Oncologists (IASGO), 2019/10/03, Without Invitation, English
  3. Safety and efficacy of novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites in liver transplant candidates, Sato K, Ohira M, Imaoka Y, Hashimoto S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H, 19th Congress of the European Society for Organ Transplantation, 2019/09/15, Without Invitation, English
  4. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for management of refractory ascites in liver transplant candidates, Sato K, Ohira M, Imaoka Y, Hashimoto S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H, 2019 American Transplant Congress, 2019/06/01, Without Invitation, Japanese
  5. Surgical strategy for the highly advanced hepatocellular carcinoma beyond BC LC classification, 2018/06/07, Without Invitation, Japanese
  6. Anatomical hepatectomy with the midline incision for right-sided liver tumors, Kobayashi T, Sho Okimoto, Shintaro Kuroda,Michinori Hamaoka,Seiichi Shimizu,Hiroyuki Tahara,Masahiro Ohira,Kentaro Ide,Kohei Ishiyama,Hideki Ohdan, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association / the 29th Annual Congress of the Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2017/06/07, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. 2018, 2020
  2. 2015
  3. KAKENHI, 2012, 2014
  4. KAKENHI, Development of the novel molecular targeted therapy against hepatocellular carcinoma invasion and metastasis, 2009, 2011

Social Activities

History as Peer Reviews of Academic Papers

  1. 2022, J Hepatobiliary Pancreat Sci, Others, reviewer, 1
  2. 2022, Hepatol Res, Others, reviewer, 1
  3. 2022, Surg Case Rep, Others, reviewer, 3
  4. 2022, J Gastroenterol, Others, reviewer, 2
  5. 2022, BMC gastroenterol, Others, reviewer, 1
  6. 2020, Transpl Int, Editor, 1
  7. 2021, Surg Case Rep, Editor, 1
  8. 2020, Surg Case Rep, Editor, 3
  9. 2019, Surg Case Rep, Editor, 1
  10. 2021, Surg Today, Editor, 1
  11. 2020, Surg Today, Editor, 5
  12. 2020, Sci Rep, Editor, 1
  13. 2020, PLoS One, Editor, 1
  14. 2020, Liver Int, Editor, 1
  15. 2020, Hepatol Res, Editor, 1
  16. 2020, Cancer Med, Editor, 3
  17. 2019, BMC Surg, Editor, 1
  18. 2019, BMC Surg, Editor, 1
  19. 2020, BMC Gastroenterol, Editor, 1
  20. 2020, BMC cancer, Editor, 1
  21. 2019, BMC cancer, Editor, 4
  22. 2019, Ann Surg Oncol, Editor, 1
  23. 2019, Am J Transplant, Editor, 1
  24. 2018, BMC Cancer, Editor, 1
  25. 2018, BMC Gastroenterol, Editor, 1
  26. 2018, Hepatol Res, Editor, 1
  27. 2018, Surg Case Rep, Editor, 1
  28. 2017, Hepatol Res, Editor, 2
  29. 2017, Oncotarget, Editor, 1
  30. 2016, Tumor Biology, Editor, 3
  31. 2016, World J Surg Oncol, Editor, 1
  32. 2016, Surg Case Rep, Editor, 3